Investment Summary

EW Healthcare Partners Invests In BreatheAmerica

On September 6, 2011, growth capital firm EW Healthcare Partners invested in healthcare services company BreatheAmerica

Investment Highlights
  • This is EW Healthcare Partners’ 7th transaction in the Healthcare Services sector.
  • This is EW Healthcare Partners’ 38th transaction in the United States.
  • This is EW Healthcare Partners’ 1st transaction in Tennessee.
Investment Fate
  • BreatheAmerica was sold to a strategic buyer in 2021.

Investment Summary

Date 2011-09-06
Target BreatheAmerica
Sector Healthcare Services
Investor(s) EW Healthcare Partners
Deal Type Venture

Target

BreatheAmerica

Nashville, Tennessee, United States
BreatheAmerica develops and operates diagnostic and treatment centers for chronic airway and immune system-related diseases. Through its allergy, sinus and asthma programs and immune therapy programs, BreatheAmerica centers concentrate the resources needed to diagnose and care for these interrelated and complex diseases that affect 25% of the country’s population. BreatheAmerica is based in Nashville, Tennessee.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

EW Healthcare Partners

Investor Investor Investor Investor Investor


Category Growth Capital Firm
Founded 1985
PE ASSETS 3.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Essex Woodlands Health Ventures is a growth equity and venture capital specialist investment firm focused on opportunities across the healthcare sector. Specific areas of interest include biotechnology, pharmaceuticals, medical devices, and healthcare services/IT. Historically, Essex invested primarily in early and later-stage situations; however, today the firm also makes growth capital investments between $20 - $60 million in companies valued between $50 - $250 million, as well as private investments in public entities (PIPEs). Essex Woodlands was formed in 1985 and offices in Palo Alto, California; New York City; Houston, Texas; Shanghai and London.


DEAL STATS #
Overall 42 of 59
Sector: Healthcare Services M&A 7 of 8
Type: Venture M&A Deals 29 of 32
State: Tennessee M&A 1 of 2
Country: United States M&A 38 of 50
Year: 2011 M&A 3 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-07-18 Victory Pharma

San Diego, California, United States

Victory Pharma, Inc., a specialty pharmaceutical company, engages in acquiring, developing and marketing prescription pharmaceutical products for the treatment of pain and related conditions. The company also develops products that treat pain and minimize side effects associated with widely-used pain therapeutics. Its products include NAPRELAN tablets for the treatment of rheumatoid arthritis, osteoarthritis, XODO for the relief of moderate to moderately sever pain, and Dolgic Plus tablets for tension headache.

Sell $127M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-11-02 Active Day

Baltimore, Maryland, United States

Active Day, Inc. is a provider of high-quality healthcare and social services to the elderly and disabled through its network of Active Day facilities.

Sell -